Dare Bioscience, Inc. Shares Authorized
Dare Bioscience, Inc. (DARE) had Shares Authorized of 240.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2026-08-13
- 2026-06-30: Common Stock, Shares Authorized 240.00M shares.
- 2026-03-31: Common Stock, Shares Authorized 240.00M shares.
- 2025-12-31: Common Stock, Shares Authorized 240.00M shares.
- 2025-09-30: Common Stock, Shares Authorized 240.00M shares.
| Period end | Common Stock, Shares Authorized | Common Stock, Shares Authorized as first filed |
|---|---|---|
| 2026-06-30 | 240.00M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 240.00M shares 10-Q · filed 2026-05-14 | |
| 2025-12-31 | 240.00M shares 10-Q · filed 2026-08-13 | |
| 2025-09-30 | 240.00M shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 240.00M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 240.00M shares 10-Q · filed 2025-05-13 | |
| 2024-12-31 | 240.00M shares 10-K · filed 2026-03-26 | |
| 2024-09-30 | 240.00M shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 240.00M shares 10-Q · filed 2024-08-12 | |
| 2024-03-31 | 240.00M shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 240.00M shares 10-K · filed 2025-03-31 | |
| 2023-09-30 | 240.00M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 240.00M shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 240.00M shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 240.00M shares 10-K · filed 2024-03-28 | |
| 2022-09-30 | 240.00M shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 120.00M shares 10-Q · filed 2022-08-09 | |
| 2022-03-31 | 120.00M shares 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 120.00M shares 10-K · filed 2023-03-30 | |
| 2021-09-30 | 120.00M shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 120.00M shares 10-Q · filed 2021-08-12 | |
| 2021-03-31 | 120.00M shares 10-Q · filed 2021-05-13 | |
| 2020-12-31 | 120.00M shares 10-K · filed 2022-03-31 | |
| 2020-09-30 | 120.00M shares 10-Q · filed 2020-11-12 | |
| 2020-06-30 | 120.00M shares 10-Q · filed 2020-08-12 | |
| 2020-03-31 | 120.00M shares 10-Q · filed 2020-05-14 | |
| 2019-12-31 | 120.00M shares 10-K · filed 2021-03-30 | |
| 2019-09-30 | 120.00M shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 120.00M shares 10-Q · filed 2019-08-14 | |
| 2019-03-31 | 120.00M shares 10-Q · filed 2019-05-14 | |
| 2018-12-31 | 120.00M shares 10-K · filed 2020-03-27 | |
| 2018-09-30 | 120.00M shares 10-Q · filed 2018-11-13 | |
| 2018-06-30 | 120.00M shares 10-Q · filed 2018-08-13 | |
| 2018-03-31 | 120.00M shares 10-Q · filed 2018-05-14 | |
| 2017-12-31 | 120.00M shares 10-K · filed 2019-04-01 | |
| 2017-09-30 | 120.00M shares 10-Q · filed 2017-11-13 | |
| 2017-06-30 | 10.00M shares 8-K/A · filed 2017-10-02 | 120.00M shares 10-Q · filed 2017-08-14 |
| 2017-03-31 | 120.00M shares 10-Q · filed 2017-05-12 | |
| 2016-12-31 | 10.00M shares 10-K · filed 2018-03-28 | 120.00M shares 10-K · filed 2017-03-31 |
| 2016-09-30 | 120.00M shares 10-Q · filed 2016-11-03 | |
| 2016-06-30 | 10.00M shares 8-K/A · filed 2017-10-02 | 120.00M shares 10-Q · filed 2016-08-04 |
| 2016-03-31 | 120.00M shares 10-Q · filed 2016-05-02 | |
| 2015-12-31 | 10.00M shares 8-K/A · filed 2017-10-02 | 120.00M shares 10-K · filed 2016-03-10 |
| 2015-09-30 | 120.00M shares 10-Q · filed 2015-11-16 | |
| 2015-06-30 | 120.00M shares 10-Q · filed 2015-08-06 | |
| 2015-03-31 | 120.00M shares 10-Q · filed 2015-05-06 | |
| 2014-12-31 | 120.00M shares 10-K · filed 2016-03-10 | |
| 2014-09-30 | 120.00M shares 10-Q · filed 2014-11-13 | |
| 2014-06-30 | 120.00M shares 10-Q · filed 2014-08-12 | |
| 2014-03-31 | 132.00M shares 10-Q · filed 2014-05-27 | |
| 2013-12-31 | 120.00M shares 10-K · filed 2015-03-19 | 132.00M shares 10-Q · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |